SEARCH

SEARCH BY CITATION

References

  • 1
    Freese DK, Snover DC, Sharp HL, Gross CR, Savvick SK, Payne WD. Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features. HEPATOLOGY 1991; 13: 882891.
  • 2
    Quiroca J, Colina I, Demetris AJ, Starzl TE, van Thiel DH. Cause and timing of first allograft failure in orthotopic liver transplantation. A study of 177 consecutive patients. HEPATOLOGY 1991; 14: 10541062.
  • 3
    Hubscher S, Neuberger J. Chronic rejection of the liver allograft. In: NeubergerJ, AdamsD, eds. Immunology of Liver Transplantation. Sevenoaks; Edward Arnaud, 1993: 216216.
  • 4
    Vierling JM, Fennel RH. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts. HEPATOLOGY 1985; 5: 10761082.
  • 5
    Demetris AJ, Qian SG, Sun H, Fung JJ. Liver allograft rejection: an overview of morphological findings. Am J Surg Pathol 1990; 14: 4963.
  • 6
    Ludwig J, International Working Party. Terminology for hepatic allograft rejection. HEPATOLOGY 1995; 22: 648654.
  • 7
    Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile duct syndrome following liver transplantation: is it reversible? Transplantation 1991; 51: 10041010.
  • 8
    Häyry P, Isoniemi H, Yilmaz S, Mennander A, Lemström K, Räisänen-Sokolowski A, et al. Chronic allograft rejection. Immunol Rev 1993; 134: 3381.
  • 9
    Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 35613566.
  • 10
    Loebe M, Schüler S, Ortwin Z, Warnecke H, Fleck E, Hetzer R. Role of Cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Lung Transplant 1990; 9: 707711.
  • 11
    Koskinen P, Nieminen M, Krogerus L, Lemström K, Mattila S, Häyry P, Lautenschlager I. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human heart allografts. J Heart Lung Transplant 1993; 12: 724729.
  • 12
    Loepez C, Simmons RL, Mauer SM, Najarian JS, Good RA. Association of renal allograft rejection with virus infections. Am J Med 1974; 56: 280289.
  • 13
    Von Willebrand E, Petterson E, Ahonen J, Häyry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986; 42: 364367.
  • 14
    Reinke P, Fietze E, Ode-Hakim S, Prösch S, Lippert J, Ewert R, Volk HD. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344: 17371738.
  • 15
    O'Grady JG, Alexander GJ, Sutherland S, Donaldson PT, Harvey FAH, Portman B, Calne RY, et al. Cytomegalovirus infection and donor/recipient HLA-antigens: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 1988; 2: 302305.
  • 16
    Arnold JC, Portman BC, O'Grady JG, Naoumov NV, Alexander GJM, Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. HEPATOLOGY 1992; 16: 285292.
  • 17
    Paya CV, Wiesner RH, Hermans PE, Larson-Keller JJ, Ilstrup DM, Krom RAF, Moore SB, et al. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. HEPATOLOGY 1992; 16: 6670.
  • 18
    Brigati DJ, Myerson D, Leaby JJ, Spalholz B, Travis SZ, Fong CKV, Hisiun GD, et al. Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labeled hybridisation probes. Virology 1983; 126: 3250.
  • 19
    Hammerer P, Arndt R, Milde K, Loenig T, Huland H. Analysis of T-cell subsets and DNA in-situ-hybridisation-a new diagnostic tool for virus infections in kidney transplants. Investig Urol 1987; 2: 241245.
  • 20
    Wiesner RH, Ludwig J, Van Hoek B, Krom RAF. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. HEPATOLOGY 1991; 14: 721729.
  • 21
    Lautenschlager I, Höckerstedt K, Salmela K, Isoniemi H, Holmberg C, Jalanko H, Häyry P. Fine needle aspiration biopsy (FNAB) in the monitoring of liver allografts; different cellular findings during rejection and CMV infection. Transplantation 1990; 50: 798803.
  • 22
    Koskimies S, Lautenschlager I. Transplantation antigens. In: NeubergerJ, AdamsD, eds. Immunology of Liver Transplantation. Sevenoaks; Edward Arnold, 1993: 127127.
  • 23
    Lautenschlager I, Höckerstedt K. Induction of ICAM-1 on hepatocytes precedes the lymphoid activation of acute liver allograft rejection and cytomegalovirus infection. Transplant Proc 1993; 25: 14291430.
  • 24
    Steinhoff G, Behrend M, Schrader B, Pichlmayr R. Intercellular immune adhesion molecules in human liver transplants: overview on expression patterns of leukocyte receptor and ligand molecules. HEPATOLOGY 1993; 18: 440453.
  • 25
    Beck S, Barrel BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 1988; 331: 269272.
  • 26
    Fujinami RS, Nelson JA, Walker L, Oldstone MB. Sequence homology and immunologic cross reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol 1988; 62: 100105.
  • 27
    Koskinen P, Lemström K, Bruggeman C, Lautenschlager I, Häyry P. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with en-changed allograft arteriosclerosis. Am J Pathol 1994; 144: 4150.
  • 28
    Lautenschlager I, Nashan B, Schlitt HJ, Hoshino K, Ringe B, Tillmann HL, Manns M, et al. Different cellular patterns associated with hepatitis C reactivation, cytomegalovirus infection and acute rejection in liver transplant patients monitored with transplant aspiration cytology. Transplantation 1994; 58: 13391345.